Carradora Health, Inc. is a woman-owned small business dedicated to serving customers in healthcare information technology solutions in both the government and commercial spaces.  Our team has an exceptional background in providing personal service and innovative solutions on a variety of projects in Healthcare IT.

Current and recent projects for government clients center on research and development to enable the interoperability of electronic health records.  These efforts include subject areas such as testing and piloting patient-reported outcomes (PRO), developing long-term electronic services and supports, and improved standards around the Prescription Drug Monitoring Program (PDMP).

The expertise we provide covers a wide range of program support, including: working with standards development organizations (SDOs) to develop standards from PSS through to balloting and publishing, managing pilots with commercial and academic centers, convening in-person and on-line meetings of SMEs and other ranging from tens to hundreds of participants, healthcare IT vocabulary support.

Our team is committed to the advancement of Healthcare IT, and EHR interoperability in particular, in order to deliver better care to patients.

Founded in 2017, JuneBrain, LLC is an early start-up company based in the Washington, DC area. Partnering with Johns Hopkins University and Stanford University, our mission is to develop a wearable and non-invasive imaging device that enables multiple sclerosis patients to monitor their disease activity at home, leading to earlier detection of MS attacks and improved monitoring of treatment efficacy. 

Healable is a Mobile Patient Engagement App that allows health care professionals to communicate with patients via secure and private video consults, text messaging and group messaging. It also allows health care professionals to co-ordinate care by allowing them to communicate with each other and to privately discuss patient cases and share relevant patient records. Patients can use this same platform to create online support groups to support and network with other patients with similar health conditions.

LinkedIn

US affiliate of EMS S/A of Brazil. Brace Pharma Capital is a strategic investment company formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors. We invest in innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options.

Clinical stage company developing therapeutics for Dechenne Muscular Dystrophy.

ExeGi leverages the growing advances in the field of the microbiome science to deliver novel, clinically supported, live biotherapeutic and probiotic treatments for a wide variety of unmet medical needs. We offer a high-potency probiotic medical food, Visbiome™, consisting of eight strains of live, freeze-dried lactic acid bacteria.  Visbiome is specially formulated for the dietary management of dysbiosis associated with IBS, ulcerative colitis, pouchitis, and hepatic encephalopathy. Visbiome is a non-drug therapy that addresses distinct nutritional requirements, to promote microbial balance, in people with IBS, ulcerative colitis, pouchitis, and hepatic encephalopathy that cannot be addressed by the modification of the diet alone. Visbiome is currently the subject of eight clinical trials, as a medical food, in several new disease states including HIV, autism spectrum disorders, and liver cirrhosis. Visbiome is intended to be used under the supervision of a physician.

Anti-bacterial plastics for housing medical devices and hospital equipment.

Victamax

In August of 2009 fNIR Devices, LLC started its operations after licensing various technologies from the estate of Dr. Britton Chance and the Drexel University.  fNIR Devices offerings, a line of Continuous Wave Functional Near Infrared imaging tools, are capable of monitoring brain’s hemodynamics and thereby the cognitive state of the subject in natural environments. fNIR technology employs specific wavelengths in an optical frequency window that can easily pass through a few centimeters for most tissues allowing monitoring of blood oxygenation changes. The relative changes of light intensity across time provide the researchers with information about neural activity.   Todate with over 250 brain imagers in the field, fNIR Devices is the premier supplier of fNIR Spectroscopy imaging systems for research and other non-clinical applications. 

Developing Innovations in Flow Cytometry

Developing a universal Pneumococcal vaccine. SynAm Vaccine's lead universal vaccine candidate addresses the critical unmet medical need in the marketplace by providing universal coverage against all 91 bacteria serotypes, while current marketed vaccines cover only a fraction of the serotypes.

Development research, analytics & consulting firm helping policy makers & development sector design data-backed policies & programs.

TruGenomix Health will launch a revolution in treatment for post-traumatic stress disorder (PTSD), offering better identification of the condition and targeted, individualized treatment options. TruGenomix is the brainchild of two veterans, Yusuf Henriques and Charles Cathlin. The two met in 2006 as scientific reviewers in the FDA's Center for Devices and Radiological Health and bonded over a shared desire to improve medical treatment for veterans and entrepreneurs' frustration at the pace of innovation.